Kaye Edward M. MD
Director at STOK; Director at CYTK; Director at SRPT
- Sold, on record
- $18.7M
- Dollars the filings state
- Form 4 sales
- 30
- Latest Aug 18, 2026
- Form 144 notices
- 14
- Proposed sales
- Quarters with a sale
- 6 of the last 8
- 16 days with a sale in that time
- Companies
- 3
- Filed as an executive or holder
Companies
Sales by reason
5
Routine
3
Plan not stated
7
No plan
15
Unusual
Form 4 sales per year, every sale on record.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- Oct 21, 2026Notice
Filed a notice to sell 1.5M shares
$38.4M1.5M shares
- Aug 18, 2026No plan
Sold 9.2% of their holdings
$403k12,567 shares at $32.03
- Jun 1, 2026Routine
Sold 22.2% of their holdings
$223k2,933 shares at $76.09
- Jun 1, 2026Notice
Filed a notice to sell 2,933 shares
$225k2,933 shares
- Dec 8, 2025Routine
Sold 21.5% of their holdings
$433k13,430 shares at $32.27
- Dec 8, 2025Notice
Filed a notice to sell 13,430 shares
$415k13,430 shares
- Dec 5, 2025Notice
Filed a notice to sell 2,181 shares
$68k2,181 shares
- Dec 5, 2025Routine
Sold 19.3% of their holdings
$467k15,001 shares at $31.13
- Dec 3, 2025No plan
Sold 4% of their holdings
$65k2,136 shares at $30.22
- Dec 1, 2025Unusual
Sold 73.8% of their holdings
$1.9M28,064 shares at $66.72
10 of 44
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Oct 20, 2026 | CYTK | Director | Awarded | 195 | $63.92 | $12k | 10,629 | SEC |
| Aug 18, 2026 | Aug 18, 2026 | STOK | Director | Sold | 12,567 | $32.03 | $403k | 124,557 | SEC |
| Aug 14, 2026 | Aug 18, 2026 | STOK | Director | Exercised or settledPerformance Stock Units | 26,250 | 0 | SEC | ||
| Aug 14, 2026 | Aug 18, 2026 | STOK | Director | Exercised options | 26,250 | 137,124 | SEC | ||
| Jul 15, 2026 | Jul 16, 2026 | CYTK | Director | Awarded | 151 | $82.62 | $12k | 10,434 | SEC |
| Jun 3, 2026 | Jun 5, 2026 | STOK | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 1, 2026 | Jun 1, 2026 | CYTK | Director | Sold | 2,933 | $76.09 | $223k | 10,283 | SEC |
| May 27, 2026 | May 27, 2026 | CYTK | Director | AwardedNon-Qualified Stock Option (Right to Buy) | 4,301 | 4,301 | SEC | ||
| May 27, 2026 | May 27, 2026 | CYTK | Director | Awarded | 2,851 | 13,216 | SEC | ||
| Apr 15, 2026 | Apr 15, 2026 | CYTK | Director | Awarded | 191 | $65.37 | $12k | 10,365 | SEC |
| Mar 15, 2026 | Mar 17, 2026 | STOK | Director | Exercised or settledRestricted Stock Units | 61,750 | 52,500 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Director | Exercised options | 61,750 | 110,874 | SEC | ||
| Feb 27, 2026 | Feb 27, 2026 | Avidity Biosciences, Inc. | Director | Returned to the companyStock Option (Right to Buy) | 103,380 | 0 | SEC | ||
| Feb 27, 2026 | Feb 27, 2026 | Avidity Biosciences, Inc. | Director | Returned to the company | 6,692 | 0 | SEC | ||
| Jan 15, 2026 | Jan 16, 2026 | CYTK | Director | Awarded | 197 | $63.44 | $12k | 10,174 | SEC |
| Dec 8, 2025 | Dec 10, 2025 | STOK | Director | Sold | 13,430 | $32.27 | $433k | 49,124 | SEC |
| Dec 5, 2025 | Dec 5, 2025 | STOK | Director | Sold | 15,001 | $31.13 | $467k | 62,554 | SEC |
| Dec 3, 2025 | Dec 5, 2025 | STOK | Director | Exercised or settledPerformance Stock Units | 26,250 | 0 | SEC | ||
| Dec 3, 2025 | Dec 5, 2025 | STOK | Director | Exercised options | 26,250 | 77,555 | SEC | ||
| Dec 3, 2025 | Dec 3, 2025 | STOK | Director | Sold | 2,136 | $30.22 | $65k | 51,305 | SEC |
| Dec 1, 2025 | Dec 3, 2025 | STOK | Director | Exercised or settledRestricted Stock Units | 4,317 | 0 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | CYTK | Director | Sold | 28,064 | $66.72 | $1.9M | 9,977 | SEC |
| Dec 1, 2025 | Dec 2, 2025 | CYTK | Director | Exercised or settledNon-Qualified Stock Option (Right to Buy) | 28,064 | 0 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | CYTK | Director | Exercised options | 28,064 | $13.72 | $385k | 38,041 | SEC |
| Nov 11, 2025 | Nov 12, 2025 | CYTK | Director | Sold | 5,175 | $65.08 | $337k | 9,977 | SEC |
| Nov 11, 2025 | Nov 12, 2025 | CYTK | Director | Exercised or settledNon-Qualified Stock Option (Right to Buy) | 5,175 | 0 | SEC | ||
| Nov 11, 2025 | Nov 12, 2025 | CYTK | Director | Exercised options | 5,175 | $9.66 | $50k | 15,152 | SEC |
| Oct 15, 2025 | Oct 16, 2025 | CYTK | Director | Awarded | 199 | $62.80 | $12k | 9,977 | SEC |
| Oct 8, 2025 | Oct 10, 2025 | STOK | Director | Sold | 25,000 | $30.00 | $750k | 49,124 | SEC |
| Oct 8, 2025 | Oct 10, 2025 | STOK | Director | Exercised or settledStock Option (Right to Buy) | 25,000 | 542,801 | SEC | ||
| Oct 8, 2025 | Oct 10, 2025 | STOK | Director | Exercised options | 25,000 | $0.60 | $15k | 74,124 | SEC |
| Oct 6, 2025 | Oct 6, 2025 | CYTK | Director | Sold | 6,757 | $60.00 | $405k | 9,778 | SEC |
| Oct 3, 2025 | Oct 7, 2025 | STOK | Director | Sold | 42,461 | $25.09 | $1.1M | 49,124 | SEC |
| Sep 30, 2025 | Sep 30, 2025 | CYTK | Director | Sold | 6,695 | $55.08 | $369k | 16,535 | SEC |
| Sep 4, 2025 | Sep 5, 2025 | STOK | Director | Returned to the companyEmployee Stock Option (Right to Buy) | 322,500 | 0 | SEC | ||
| Sep 3, 2025 | Sep 3, 2025 | STOK | Director | Sold | 61,885 | $20.13 | $1.2M | 91,585 | SEC |
| Sep 2, 2025 | Sep 2, 2025 | CYTK | Director | Sold | 6,756 | $50.00 | $338k | 23,230 | SEC |
| Aug 18, 2025 | Aug 20, 2025 | STOK | Director | Sold | 12,126 | $18.24 | $221k | 153,470 | SEC |
| Aug 14, 2025 | Aug 18, 2025 | STOK | Director | Exercised or settledPerformance Stock Units | 26,250 | 26,250 | SEC | ||
| Aug 14, 2025 | Aug 18, 2025 | STOK | Director | Exercised options | 26,250 | 165,596 | SEC | ||
| Aug 14, 2025 | Aug 18, 2025 | STOK | Director | AwardedPerformance Stock Units | 52,500 | 52,500 | SEC | ||
| Jul 15, 2025 | Jul 16, 2025 | CYTK | Director | Awarded | 328 | $38.01 | $12k | 29,986 | SEC |
| Jun 10, 2025 | Jun 12, 2025 | Avidity Biosciences, Inc. | Director | AwardedStock Option (Right to Buy) | 10,034 | 10,034 | SEC | ||
| Jun 10, 2025 | Jun 12, 2025 | Avidity Biosciences, Inc. | Director | Awarded | 6,692 | 6,692 | SEC | ||
| Jun 5, 2025 | Jun 5, 2025 | CYTK | Director | Sold | 3,636 | $32.10 | $117k | 29,658 | SEC |
| May 14, 2025 | May 14, 2025 | CYTK | Director | AwardedNon-Qualified Stock Option (Right to Buy) | 10,880 | 10,880 | SEC | ||
| May 14, 2025 | May 14, 2025 | CYTK | Director | Awarded | 7,333 | 33,294 | SEC | ||
| Apr 15, 2025 | Apr 16, 2025 | CYTK | Director | Awarded | 324 | $38.56 | $12k | 25,961 | SEC |
| Mar 20, 2025 | Mar 20, 2025 | STOK | Director | AwardedEmployee Stock Option (Right to Buy) | 360,000 | 144,000 | SEC | ||
| Mar 19, 2025 | Mar 20, 2025 | STOK | Director | Sold | 19,289 | $8.49 | $164k | 139,346 | SEC |
Page 1
Sales and notices (44)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | Oct 21, 2026 | STOK | Director | Form 144 notice | 1.5M | $38.4M | Notice | SEC | |
| Aug 18, 2026 | Aug 18, 2026 | STOK | Director | Form 4 sale | 12,567 | $403k | 9.2% | No plan | SEC |
| Jun 1, 2026 | Jun 1, 2026 | CYTK | Director | Form 4 sale | 2,933 | $223k | 22.2% | Routine | SEC |
| Jun 1, 2026 | Jun 1, 2026 | CYTK | Director | Form 144 notice | 2,933 | $225k | Notice | SEC | |
| Dec 8, 2025 | Dec 10, 2025 | STOK | Director | Form 4 sale | 13,430 | $433k | 21.5% | Routine | SEC |
| Dec 8, 2025 | Dec 8, 2025 | STOK | Director | Form 144 notice | 13,430 | $415k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | STOK | Director | Form 144 notice | 2,181 | $68k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | STOK | Director | Form 4 sale | 15,001 | $467k | 19.3% | Routine | SEC |
| Dec 3, 2025 | Dec 3, 2025 | STOK | Director | Form 4 sale | 2,136 | $65k | 4.0% | No plan | SEC |
| Dec 1, 2025 | Dec 2, 2025 | CYTK | Director | Form 4 sale | 28,064 | $1.9M | 73.8% | Unusual | SEC |
| Dec 1, 2025 | Dec 1, 2025 | CYTK | Director | Form 144 notice | 28,064 | $1.9M | Notice | SEC | |
| Nov 11, 2025 | Nov 12, 2025 | CYTK | Director | Form 4 sale | 5,175 | $337k | 34.2% | Unusual | SEC |
| Nov 11, 2025 | Nov 12, 2025 | CYTK | Director | Form 144 notice | 5,175 | $322k | Notice | SEC | |
| Oct 8, 2025 | Oct 10, 2025 | STOK | Director | Form 4 sale | 25,000 | $750k | 33.7% | Unusual | SEC |
| Oct 8, 2025 | Oct 8, 2025 | STOK | Director | Form 144 notice | 25,000 | $683k | Notice | SEC | |
| Oct 6, 2025 | Oct 6, 2025 | CYTK | Director | Form 4 sale | 6,757 | $405k | 40.9% | Unusual | SEC |
| Oct 6, 2025 | Oct 6, 2025 | CYTK | Director | Form 144 notice | 6,757 | $385k | Notice | SEC | |
| Oct 3, 2025 | Oct 7, 2025 | STOK | Director | Form 4 sale | 42,461 | $1.1M | 46.4% | Unusual | SEC |
| Oct 3, 2025 | Oct 3, 2025 | STOK | Director | Form 144 notice | 42,461 | $1.1M | Notice | SEC | |
| Sep 30, 2025 | Sep 30, 2025 | CYTK | Director | Form 4 sale | 6,695 | $369k | 28.8% | Unusual | SEC |
| Sep 30, 2025 | Sep 30, 2025 | CYTK | Director | Form 144 notice | 6,695 | $361k | Notice | SEC | |
| Sep 3, 2025 | Sep 3, 2025 | STOK | Director | Form 4 sale | 61,885 | $1.2M | 40.3% | Unusual | SEC |
| Sep 2, 2025 | Sep 2, 2025 | CYTK | Director | Form 4 sale | 6,756 | $338k | 22.5% | Routine | SEC |
| Sep 2, 2025 | Sep 2, 2025 | CYTK | Director | Form 144 notice | 6,756 | $239k | Notice | SEC | |
| Aug 29, 2025 | Aug 29, 2025 | STOK | Director | Form 144 notice | 61,885 | $1.2M | Notice | SEC | |
| Aug 18, 2025 | Aug 20, 2025 | STOK | Director | Form 4 sale | 12,126 | $221k | 7.3% | No plan | SEC |
| Jun 5, 2025 | Jun 5, 2025 | CYTK | Director | Form 144 notice | 3,636 | $118k | Notice | SEC | |
| Jun 5, 2025 | Jun 5, 2025 | CYTK | Director | Form 4 sale | 3,636 | $117k | 10.9% | Routine | SEC |
| Mar 19, 2025 | Mar 20, 2025 | STOK | Director | Form 4 sale | 19,289 | $164k | 12.2% | No plan | SEC |
| Dec 9, 2024 | Dec 11, 2024 | STOK | CEO | Form 4 sale | 6,786 | $88k | 9.9% | No plan | SEC |
| Dec 6, 2024 | Dec 10, 2024 | STOK | CEO | Form 4 sale | 6,170 | $79k | 8.2% | No plan | SEC |
| May 20, 2024 | May 22, 2024 | STOK | CEO | Form 4 sale | 42,350 | $654k | 61.1% | Unusual | SEC |
| May 20, 2024 | May 20, 2024 | STOK | Director | Form 144 notice | 42,350 | $589k | Notice | SEC | |
| Mar 19, 2024 | Mar 19, 2024 | STOK | CEO | Form 4 sale | 11,150 | $68k | 13.9% | No plan | SEC |
| Aug 5, 2022 | Aug 8, 2022 | CYTK | Director | Form 4 sale | 11,428 | $571k | 47.6% | Unusual | SEC |
| Dec 23, 2021 | Dec 23, 2021 | CYTK | Director | Form 4 sale | 15,000 | $675k | 68.9% | Unusual | SEC |
| Dec 18, 2020 | Dec 18, 2020 | STOK | CEO | Form 4 sale | 25,000 | $1.5M | 100.0% | Unusual | SEC |
| Nov 27, 2020 | Nov 30, 2020 | STOK | CEO | Form 4 sale | 12,152 | $608k | 32.7% | Unusual | SEC |
| Nov 25, 2020 | Nov 25, 2020 | STOK | CEO | Form 4 sale | 12,848 | $642k | 25.7% | Unusual | SEC |
| Oct 5, 2020 | Oct 5, 2020 | CYTK | Director | Form 4 sale | 20,000 | $600k | 100.0% | Unusual | SEC |
| Jul 20, 2017 | Jul 21, 2017 | SRPT | Director | Form 4 sale | 10,000 | $410k | 16.0% | Plan not stated | SEC |
| Sep 22, 2016 | Sep 26, 2016 | SRPT | President, CEO & CMO | Form 4 sale | 40,179 | $2.4M | 34.3% | Unusual | SEC |
| Sep 19, 2016 | Sep 21, 2016 | SRPT | President, CEO & CMO | Form 4 sale | 24,352 | $1.2M | 24.0% | Plan not stated | SEC |
| Sep 14, 2016 | Sep 16, 2016 | SRPT | SVP Interim CEO & CMO | Form 4 sale | 24,557 | $737k | 24.2% | Plan not stated | SEC |